Judge Axes IP Suit Over Xifaxan, Ruling The Drug Is Prior Art

By Britain Eakin (August 17, 2022, 5:58 PM EDT) -- A New Jersey federal judge on Wednesday dismissed an infringement suit against Bausch Health unit Salix Pharmaceuticals Ltd. over its drug Xifaxan after finding the drug product actually constitutes prior art to the four patents it was accused of infringing....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!